$TNYA
Tenaya Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · South San Francisco, CA
TNYA chart
What traders are saying about $TNYA
Latest postsTenaya Therapeutics, Inc. news
- Form DEF 14A Tenaya Therapeutics Inc For: 24 October By Investing.com
Investing.com Nigeria ·
- Tenaya Therapeutics Schedules December 9 Vote on Reverse Stock Split Proposal
Kalkine Media ·
- Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
Yahoo Finance ·
- Treasury yields rise as investors raise bets on Fed rate hike: AlphaCheck
Yahoo Finance ·
- Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
Yahoo Finance ·
- Tenaya Therapeutics Eyes Q4 Updates for Cardiac Gene Therapies, TN-301
marketbeat.com ·
- Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
Yahoo Finance ·
- Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance ·
- Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
Yahoo Finance ·
- Exploring 3 High Growth Tech Stocks in US Market
Yahoo Finance ·
- Exploring High Growth Tech Stocks In The US Market
Yahoo Finance ·
Tenaya Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$90.6M | -$111.1M | -$124.1M | -$123.7M |
| Diluted EPS | $-0.59 | $-1.31 | $-1.68 | $-2.76 |
| Total assets (year end) | $146.9M | $119.9M | $170.5M | $278.9M |
| Cash and equivalents (year end) | $100.5M | $4.3M | $45.7M | $95.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Tenaya Therapeutics, Inc.
- Ticker
- TNYA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1858848
Frequently asked questions
What exchange is Tenaya Therapeutics, Inc. listed on?
Tenaya Therapeutics, Inc. trades on the Nasdaq under the ticker symbol TNYA.
What industry is Tenaya Therapeutics, Inc. in?
Tenaya Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Tenaya Therapeutics, Inc. headquartered?
Tenaya Therapeutics, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Tenaya Therapeutics, Inc.'s fiscal year end?
Tenaya Therapeutics, Inc.'s fiscal year ends on December 31.